TY - JOUR
T1 - Dural venous sinus stenting in patients with idiopathic intracranial hypertension
T2 - report of outcomes from a single-center prospective database and literature review
AU - Kole, Matthew J.
AU - Martinez-Gutierrez, Juan Carlos
AU - Sanchez, Francisio
AU - Tang, Rosa
AU - Chen, Peng Roc
N1 - Funding Information:
was supplied by the Weatherhead Foundation (PR Chen).
Publisher Copyright:
© 2022 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2022
Y1 - 2022
N2 - Introduction: Idiopathic intracranial hypertension (IIH) is a disease of excess cerebrospinal fluid (CSF) leading to rising intracranial pressure. Patients most commonly present with headache, tinnitus, papilledema, and vision loss. It most commonly affects young overweight females, a growing population. Traditional management has consisted of weight loss, medical management, surgical CSF diversion, and optic nerve sheath fenestration. In recent years, cerebral venous sinus stenosis has been described as an almost ubiquitously present potentiator of this disease. Venous sinus stenting to normalize cerebral venous outflow has emerged as a highly effective treatment. Areas covered: In this review, the authors review the epidemiology and pathophysiology of IIH, as well as its common management strategies. The authors focus on the emergence of venous sinus stenting as a safe, effective, and minimally invasive strategy for managing IIH. Expert opinion: IIH caused by venous sinus stenosis can be treated effectively and safely with endovascular stenting of the sinus. Given its low morbidity and failure rate relative to other traditional management strategies, evaluation for venous sinus stenosis should be pursued in this patient population, and referral to a neuro-endovascular specialist made if indicated.
AB - Introduction: Idiopathic intracranial hypertension (IIH) is a disease of excess cerebrospinal fluid (CSF) leading to rising intracranial pressure. Patients most commonly present with headache, tinnitus, papilledema, and vision loss. It most commonly affects young overweight females, a growing population. Traditional management has consisted of weight loss, medical management, surgical CSF diversion, and optic nerve sheath fenestration. In recent years, cerebral venous sinus stenosis has been described as an almost ubiquitously present potentiator of this disease. Venous sinus stenting to normalize cerebral venous outflow has emerged as a highly effective treatment. Areas covered: In this review, the authors review the epidemiology and pathophysiology of IIH, as well as its common management strategies. The authors focus on the emergence of venous sinus stenting as a safe, effective, and minimally invasive strategy for managing IIH. Expert opinion: IIH caused by venous sinus stenosis can be treated effectively and safely with endovascular stenting of the sinus. Given its low morbidity and failure rate relative to other traditional management strategies, evaluation for venous sinus stenosis should be pursued in this patient population, and referral to a neuro-endovascular specialist made if indicated.
KW - Pseudotumor
KW - idiopathic intracranial hypertension
KW - papilledema
KW - venous sinus stenosis
UR - http://www.scopus.com/inward/record.url?scp=85142250951&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85142250951&partnerID=8YFLogxK
U2 - 10.1080/17469899.2022.2139678
DO - 10.1080/17469899.2022.2139678
M3 - Review article
AN - SCOPUS:85142250951
SN - 1746-9899
VL - 17
SP - 321
EP - 331
JO - Expert Review of Ophthalmology
JF - Expert Review of Ophthalmology
IS - 5
ER -